Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 29  •  04:00PM ET
24.02
Dollar change
-0.95
Percentage change
-3.80
%
Category
Equity - Leveraged / Inverse
Asset Type
Equities (Stocks)
Tags
Return% 1Y
79.61%
Total Holdings
9
Perf Week
12.14%
Sponsor
Defiance ETFs
ETF Type
Tags
Return% 3Y
-
AUM
60.82M
Perf Month
65.09%
Fund Family
Bond Type
Tags
Return% 5Y
-
NAV/sh
Perf Quarter
3.67%
Index
-
Average Maturity
Tags
Return% 10Y
52W High
28.44 -15.54%
Perf Half Y
-15.42%
Index Weighting
Commodity Type
Tags
-
Return% SI
52W Low
9.60 150.21%
Perf YTD
-5.77%
Active/Passive
Quant Type
Tags
-
Flows% 1M
-29.27%
Volatility
5.92% 6.03%
Perf Year
74.18%
ESG Type
Tags
-
Flows% 3M
23.59%
ATR (14)
1.29
Perf 3Y
-
Dividend Type
Sector/Theme
Flows% YTD
74.40%
RSI (14)
68.88
Perf 5Y
-
Structure Type
Region
Flows% 1Y
Beta
0.72
Perf 10Y
-
Expense
1.32%
Growth/Value
SMA20
17.34%
Flows% 3Y
Rel Volume
1.04
Prev Close
24.97
Inverse/Leveraged
Market Cap
SMA50
30.66%
Flows% 5Y
Avg Volume
466.98K
Price
24.02
IPO
Aug 08, 2024
Option/Short
Yes / Yes
SMA200
22.74%
Trades
Volume
486,129
Change
-3.80%
Apr-22-25 08:07AM
Defiance Daily Target 2X Long LLY ETF seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Eli Lilly and Company. The fund will enter into one or more swap agreements with financial institutions for a specified period, which may range from one day to longer than a year. The advisor has adopted a policy to have at least 80% exposure to financial instruments with economic characteristics that should perform 2X the daily performance of the underlying security's shares. The fund is non-diversified.